Novavax Inc.’s COVID-19 vaccine is on its way towards authorization from the FDA after formally submitting a request in late January. The company says it has resolved the manufacturing issues that had delayed their application, and now expects approval from the FDA in the coming weeks.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
